NHSBT Research and Development
Welcome to NHSBT Research and Development
Research and Development is fundamental to NHSBT, to deliver even safer and more effective treatments for patients in the future.
Research across NHSBT now involves 17 Principal Investigators, nearly 200 staff and a total budget of £16 million a year. The
main research sites, in collaboration with University partners, are Cambridge, Oxford, London and Bristol, with specialist
activity in Birmingham and Liverpool.
Our supporting infrastructure consists of the Clinical Biotechnology Centre (Bristol), which manufactures GMP-grade biologicals
for Phase 1 clinical trials, the NHSBT/MRC Clinical Studies Unit (Oxford/Cambridge/London), which supports clinical studies
and trials, the Systematic Reviews Initiative (Oxford) and the Statistics and Clinical Audit team (Bristol).
On these pages you can find out about our current NIHR programmes, workpackages and projects, and read our latest Triennial
Report which reviews projects from 2009-12.
Triennial Report 2009-12